MaltSci 麦伴科研

Appearance

Popular Reports / structural-biology

This report is written by MaltSci based on the latest literature and research findings

What is the role of intrinsically disordered proteins? ​

Abstract ​

Intrinsically disordered proteins (IDPs) have emerged as pivotal players in cellular processes, representing a paradigm shift in our understanding of protein functionality and structure. Unlike traditional globular proteins that adopt stable conformations, IDPs exist as dynamic ensembles, allowing them to participate in diverse biological functions such as signaling, regulation, and protein-protein interactions. This review explores the multifaceted roles of IDPs, beginning with their structural characteristics and dynamics, which enable their high conformational flexibility and binding plasticity. The discussion extends to their involvement in cellular signaling pathways, where IDPs mediate complex interactions and serve as scaffolds in regulatory networks. Furthermore, IDPs are implicated in disease mechanisms, particularly in neurodegenerative disorders and cancer, where their dysregulation can lead to pathological outcomes. The therapeutic implications of IDPs are also considered, highlighting their potential as drug targets and biomarkers. Recent advancements in research methodologies are enhancing our understanding of IDPs, opening new avenues for exploration in both health and disease contexts. This comprehensive analysis emphasizes the importance of IDPs in molecular biology and their potential for innovative biomedical applications.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Characteristics of Intrinsically Disordered Proteins
    • 2.1 Structural Features and Dynamics
    • 2.2 Methods for Studying IDPs
  • 3 Biological Functions of IDPs
    • 3.1 Role in Cellular Signaling
    • 3.2 Involvement in Protein-Protein Interactions
  • 4 IDPs in Disease Mechanisms
    • 4.1 IDPs and Neurodegenerative Diseases
    • 4.2 IDPs in Cancer Biology
  • 5 Therapeutic Implications of IDPs
    • 5.1 Targeting IDPs for Drug Development
    • 5.2 Potential Biomarkers for Disease
  • 6 Future Directions in IDP Research
    • 6.1 Emerging Techniques and Approaches
    • 6.2 Unexplored Roles of IDPs
  • 7 Summary

1 Introduction ​

Intrinsically disordered proteins (IDPs) represent a significant paradigm shift in our understanding of protein functionality and structure. Unlike their globular counterparts, which adopt stable three-dimensional conformations to fulfill specific biological roles, IDPs lack a fixed structure, existing instead as dynamic ensembles of conformations. This unique characteristic enables IDPs to participate in a myriad of cellular processes, including signaling, regulation, and interactions with other biomolecules. The growing recognition of IDPs' roles in both health and disease has spurred extensive research, making them a focal point in contemporary biomedicine [1][2].

The significance of IDPs lies in their versatility and adaptability. They are implicated in numerous biological functions, acting as molecular scaffolds, regulatory hubs, and mediators of complex protein-protein interactions [3][4]. Their intrinsic disorder allows for high levels of flexibility, enabling them to engage in diverse binding modes that are often unattainable by ordered proteins [1]. This binding plasticity is particularly evident in their involvement in critical processes such as gene regulation, cellular signaling, and the modulation of biomolecular condensates [5][6].

Despite their importance, the study of IDPs presents unique challenges. Traditional structural biology techniques often fall short in capturing the dynamic nature of these proteins, leading researchers to employ computational methods and innovative experimental approaches to elucidate their functions [2][7]. The understanding of IDPs has evolved from viewing them as mere anomalies in the protein structure-function paradigm to recognizing their essential roles in various biological contexts [8].

This review aims to explore the multifaceted roles of IDPs, organized into several key sections. First, we will examine the characteristics of IDPs, focusing on their structural features and dynamics, as well as the methods employed to study them. Next, we will delve into their biological functions, highlighting their roles in cellular signaling and protein-protein interactions. We will then investigate the involvement of IDPs in disease mechanisms, particularly in neurodegenerative diseases and cancer biology. Following this, we will discuss the therapeutic implications of IDPs, including their potential as drug targets and biomarkers for disease. Lastly, we will outline future directions in IDP research, emphasizing emerging techniques and unexplored roles that could further illuminate their significance in molecular biology and medicine.

Through this comprehensive analysis, we aim to provide insights into how IDPs challenge traditional views of protein function and stability, and how their dynamic nature can be harnessed for innovative biomedical strategies. The implications of IDPs extend beyond basic research, offering potential avenues for therapeutic intervention and biomarker discovery in various diseases, underscoring their importance in the broader context of molecular biology and medicine [4][6].

2 Characteristics of Intrinsically Disordered Proteins ​

2.1 Structural Features and Dynamics ​

Intrinsically disordered proteins (IDPs) represent a significant class of proteins characterized by their lack of stable tertiary and/or secondary structures under physiological conditions. This intrinsic disorder is not merely a consequence of their structural characteristics; rather, it plays a pivotal role in their biological functions. IDPs are highly prevalent across various organisms and are involved in numerous cellular processes, particularly in signaling, regulation, and protein-protein interactions.

The structural features of IDPs contribute to their unique functional capabilities. IDPs exhibit a high level of intrinsic dynamics and flexibility, allowing them to adopt multiple conformations. This conformational plasticity is essential for mediating interactions with a variety of binding partners, enabling them to participate in complex regulatory networks. For instance, in the context of protein-ligand interactions, IDPs often undergo a coupled binding and folding process, wherein they fold into stable structures upon binding to specific targets. This dynamic behavior is crucial for the organization of cellular decision-making processes, as it allows IDPs to act as versatile modulators of signaling pathways [8].

In particular, the disordered regions of proteins are critical for their biological activity. For example, the proteins of flaviviruses, such as Zika and dengue viruses, contain intrinsically disordered regions that are essential for their function. These disordered segments allow the proteins to adopt various conformations, enhancing their ability to interact with multiple ligands and stabilize particular folds. The concept of a "folding energy waterfall" is often used to describe how disordered proteins navigate their folding landscape, emphasizing the importance of disorder in achieving functional diversity [3].

Furthermore, IDPs are implicated in numerous human diseases, including cancer and neurodegenerative disorders. Their roles in these conditions often stem from their capacity to interact with multiple partners, which can lead to dysregulation of cellular pathways when the intrinsic disorder is mismanaged. For example, proteins like alpha-synuclein and tau, which are associated with neurodegenerative diseases, exemplify how intrinsic disorder can contribute to pathophysiology through aberrant signaling and protein interactions [9].

In summary, intrinsically disordered proteins are characterized by their structural flexibility and dynamic nature, which enable them to fulfill a variety of essential roles in cellular processes. Their ability to mediate diverse interactions and regulatory functions highlights their significance in both normal biological processes and the development of diseases. Understanding the intricate relationship between intrinsic disorder and protein function is crucial for advancing therapeutic strategies targeting these versatile proteins [1][10][11].

2.2 Methods for Studying IDPs ​

Intrinsically disordered proteins (IDPs) play a crucial role in various biological processes due to their unique structural characteristics and functional capabilities. IDPs are defined by their lack of stable, three-dimensional structures, which allows them to adopt multiple conformations and interact with a variety of biomolecules. This conformational malleability enables IDPs to participate in diverse cellular functions, including cellular signaling, regulation, and the assembly of protein complexes.

One of the primary roles of IDPs is their involvement in cellular signaling pathways. They can undergo combinatorial post-translational modifications and alternative splicing, which adds complexity to regulatory networks and facilitates tissue-specific signaling. For instance, IDPs are essential for the assembly of signaling complexes and the dynamic self-assembly of membrane-less organelles, which are crucial for cellular organization and function (Wright and Dyson, 2015) [12]. Furthermore, IDPs can mediate specific biological outcomes through multivalent weak cooperative interactions with multiple partners, thereby facilitating the co-option of ancestral pathways for specialized functions, as evidenced in the evolution of multicellularity in organisms like Volvox carteri (Kulkarni et al., 2022) [13].

The characteristics of IDPs are equally significant. They typically exhibit low sequence complexity and non-globular tertiary structures, allowing them to act as scaffolds and regulatory hubs. IDPs often fold into stable structures upon binding to specific targets, highlighting the importance of coupled binding and folding processes in their functionality (Click et al., 2010) [8]. The inherent structural disorder of these proteins provides them with functional advantages, particularly in dynamic cellular environments where flexibility and adaptability are required (Chen, 2012) [14].

Studying IDPs poses unique challenges due to their conformational heterogeneity and the transient nature of their structures. Traditional experimental methods may not adequately capture the dynamics of IDPs. Consequently, a combination of experimental, computational, and bioinformatic approaches is often employed to identify and characterize disordered regions. Techniques such as nuclear magnetic resonance (NMR) spectroscopy, circular dichroism (CD), and small-angle X-ray scattering (SAXS) are commonly used to investigate the structural properties of IDPs. Additionally, molecular modeling and simulations can provide insights into the functional mechanisms of IDPs and their interactions with other biomolecules (Clerc et al., 2021) [15].

In summary, intrinsically disordered proteins are integral to numerous biological processes due to their structural versatility and ability to engage in complex interactions. Their study requires innovative approaches that integrate various methodologies to unravel their roles in cellular functions and disease mechanisms.

3 Biological Functions of IDPs ​

3.1 Role in Cellular Signaling ​

Intrinsically disordered proteins (IDPs) play a critical role in cellular signaling and regulation due to their unique structural characteristics and functional versatility. Unlike structured proteins, IDPs lack stable tertiary and secondary structures under physiological conditions, allowing them to exist as dynamic ensembles of conformations. This inherent flexibility enables IDPs to interact with multiple binding partners, which is crucial for various cellular processes.

One of the primary functions of IDPs in cellular signaling is their ability to mediate complex protein-protein interactions. They often engage in high-specificity/low-affinity interactions, which are vital for the formation of signaling complexes. This feature allows IDPs to participate in the assembly of these complexes, contributing to the dynamic self-assembly of membrane-less organelles within the nucleus and cytoplasm [12]. The combinatorial nature of post-translational modifications and alternative splicing further enhances the regulatory networks in which IDPs operate, facilitating tissue-specific signaling and responses to various stimuli [12].

IDPs are also involved in regulating critical cellular pathways, including those related to cell cycle control and programmed cell death. For instance, the IDPs p21 and p27 have been shown to regulate cell cycle progression by interacting with cyclin-dependent kinases (Cdks). The structural adaptability of these proteins allows them to recognize and bind to various Cdk-cyclin complexes, thereby influencing cell division [16]. Additionally, IDPs play a significant role in programmed cell death (PCD), where their intrinsic disorder contributes to the regulation of apoptosis, autophagy, and necroptosis pathways [17].

Moreover, IDPs can act as scaffolds and regulatory hubs, facilitating the coalescence of signaling pathways. Their ability to undergo conformational changes upon binding to targets allows them to transition between disordered and ordered states, which is essential for modulating cellular responses [18]. This property also contributes to the phenomenon of "conformational noise," which can lead to increased promiscuous interactions and the activation of latent signaling pathways in response to stress [19].

In summary, the roles of intrinsically disordered proteins in cellular signaling are multifaceted. They serve as essential components of signaling networks, enabling dynamic interactions that govern cellular decision-making processes. Their ability to facilitate complex interactions and participate in diverse regulatory mechanisms underscores their significance in maintaining cellular homeostasis and responding to environmental changes. Understanding the functional dynamics of IDPs can provide valuable insights into their contributions to health and disease, particularly in the context of various human diseases where dysregulation of IDPs is implicated [9].

3.2 Involvement in Protein-Protein Interactions ​

Intrinsically disordered proteins (IDPs) play a pivotal role in various biological functions, particularly through their involvement in protein-protein interactions. IDPs are characterized by the absence of stable tertiary and/or secondary structures under physiological conditions, which allows them to engage in dynamic interactions with multiple partners. This unique structural feature enables IDPs to function as versatile regulators within cellular signaling and regulatory networks.

One of the fundamental roles of IDPs is their ability to bind to multiple partners, facilitating high-specificity/low-affinity interactions that are crucial for numerous biological processes. These interactions often involve transient complexes, which can be essential for signaling pathways, as they allow for rapid and reversible associations. For instance, IDPs can act as molecular scaffolds, bringing together various signaling molecules to form functional complexes that are critical for cellular responses to environmental stimuli [9].

Moreover, IDPs exhibit binding promiscuity, meaning they can interact with various proteins and other biomolecules, which enhances their functional repertoire. This property is particularly important in complex cellular environments where the integration of multiple signals is necessary. The transient nature of these interactions, facilitated by short interaction-prone segments within IDPs, allows for flexible and adaptable responses to cellular conditions [20].

In the context of human diseases, many IDPs are associated with crucial protein-protein interaction networks. For example, the tumor suppressor protein p53, which is intrinsically disordered, serves as a hub within its interaction network, playing a significant role in regulating cellular responses to stress and DNA damage [21]. Similarly, α-synuclein, an IDP implicated in Parkinson's disease, participates in critical interactions that can lead to pathological outcomes when misregulated [8].

Furthermore, the role of IDPs in mediating protein-protein interactions is also highlighted in drug discovery efforts. Given their dynamic nature and the unique features of their interactions, IDPs represent attractive targets for the development of therapeutic agents. Strategies to modulate IDP-mediated interactions can lead to the identification of novel drug candidates that can influence disease-related pathways [22].

In summary, the involvement of intrinsically disordered proteins in protein-protein interactions is a key aspect of their biological function. Their capacity to engage in diverse and dynamic interactions not only facilitates critical cellular processes but also underscores their importance in the context of human diseases and therapeutic interventions.

4 IDPs in Disease Mechanisms ​

4.1 IDPs and Neurodegenerative Diseases ​

Intrinsically disordered proteins (IDPs) play a crucial role in various disease mechanisms, particularly in neurodegenerative diseases. These proteins are characterized by their lack of stable tertiary and/or secondary structures under physiological conditions, which allows them to engage in a wide array of biological functions. IDPs are abundant in nature and are involved in critical processes such as regulation, signaling, and control, often through interactions with multiple partners and exhibiting high specificity in low-affinity interactions [9].

In the context of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, IDPs are implicated in the formation of protein aggregates that are associated with disease pathogenesis. For instance, the tau protein, a well-known IDP, forms paired helical filaments (PHFs) that are central to the pathology of Alzheimer's disease. The aggregation of tau protein is believed to occur through a binding-folding event, leading to neurotoxic fibril formation, which is a hallmark of neurodegeneration [23].

The role of IDPs in neurodegenerative diseases extends beyond mere aggregation. Many IDPs are involved in the modulation of cellular processes, and their dysregulation can contribute to the pathophysiology of diseases. For example, α-synuclein, another IDP, is closely associated with Parkinson's disease and is known to form toxic aggregates that disrupt neuronal function [9]. Furthermore, the dynamic nature of IDPs allows them to participate in one-to-many and many-to-one signaling, making them pivotal in the regulatory networks that underlie cellular decision-making processes [8].

The understanding of IDPs has evolved to highlight their dual role in both normal physiological functions and pathological conditions. The D2 concept, introduced by Uversky et al., emphasizes that IDPs can contribute to human diseases not only through misfolding but also via misidentification and missignaling, indicating that the functional diversity of IDPs is crucial for cellular health [9]. This highlights the need for therapeutic strategies that target IDPs to modulate their functions and mitigate their contributions to disease [24].

Recent advancements in research have focused on developing strategies to target IDPs effectively, recognizing their potential as drug targets despite the challenges posed by their structural characteristics [6]. Approaches such as proteasome activation have been proposed as novel strategies for modulating the degradation of IDPs, which may help in addressing the accumulation of these proteins in various pathological conditions [24].

In summary, IDPs are integral to the mechanisms underlying neurodegenerative diseases, influencing both the progression of these conditions through aggregation and their regulatory roles in cellular processes. The continued exploration of IDPs will likely yield new insights into therapeutic interventions for neurodegenerative diseases, aiming to restore cellular function and mitigate disease progression.

4.2 IDPs in Cancer Biology ​

Intrinsically disordered proteins (IDPs) are a significant class of proteins characterized by their lack of a stable tertiary structure under physiological conditions. They play crucial roles in various biological processes and are increasingly recognized for their involvement in disease mechanisms, particularly in cancer biology.

IDPs are abundant in proteomes and are essential for numerous cellular functions, including regulation and signaling. Their flexible nature allows them to interact with multiple partners and engage in high-specificity, low-affinity interactions, which are critical for cellular decision-making and regulatory networks [9]. In the context of cancer, IDPs have been implicated in the progression and development of various malignancies due to their roles in cell signaling and regulation [25].

The dynamic nature of IDPs poses challenges for conventional drug design, as they often do not have well-defined binding pockets. Despite these challenges, IDPs are attractive therapeutic targets due to their involvement in key pathways associated with cancer [24]. For instance, several IDPs, such as p53 and alpha-synuclein, have been identified as hub proteins in their respective interaction networks, indicating their central role in regulating cellular processes that are frequently dysregulated in cancer [8].

Recent studies have shown that mutations in IDRs can act as drivers of cancer, with approximately 20% of cancer drivers being primarily targeted through disordered regions [26]. These mutations can alter the functional mechanisms of IDPs, allowing them to engage in context-dependent interactions that influence critical biological processes such as transcription and protein degradation [26]. Moreover, the modulation of IDPs through small molecules has shown promise in disrupting the aberrant interactions that contribute to cancer [25].

In addition to direct interactions, IDPs can also influence cellular pathways through post-translational modifications, which can affect their stability and interactions with other biomolecules [8]. The study of IDPs has led to the development of novel strategies for drug discovery, focusing on targeting the disordered regions to modulate their function in disease [27].

Overall, the role of IDPs in cancer biology is multifaceted, involving regulation of signaling pathways, interactions with various cellular partners, and implications in the pathology of cancer. As research progresses, understanding the unique properties and functions of IDPs will be critical for developing effective therapeutic strategies against cancer and other diseases associated with protein dysregulation.

5 Therapeutic Implications of IDPs ​

5.1 Targeting IDPs for Drug Development ​

Intrinsically disordered proteins (IDPs) and intrinsically disordered protein regions (IDPRs) are characterized by their lack of stable, well-defined tertiary structures under physiological conditions. Despite this inherent disorder, IDPs play crucial roles in various biological processes and have significant implications for therapeutic development. Their unique properties enable them to participate in multiple interactions and regulatory mechanisms, which are pivotal in the context of numerous diseases, including cancer, neurodegenerative disorders, and metabolic conditions.

IDPs are involved in critical cellular functions such as signaling, regulation, and molecular recognition. They often act as hubs within protein-protein interaction networks, facilitating diverse biological activities. For instance, proteins like p53 and α-synuclein, both classified as IDPs, are central to tumor suppression and neurodegenerative processes, respectively. Their ability to engage in "one to many" and "many to one" interactions is largely due to their flexible conformations, allowing them to adapt to various binding partners and participate in complex regulatory networks [8][27].

The therapeutic implications of targeting IDPs are profound. Traditional drug discovery approaches have struggled with IDPs due to their dynamic nature and the absence of fixed structures, which complicates the identification of suitable binding sites for small molecules. However, recent advancements in experimental techniques and computational modeling have begun to address these challenges, paving the way for innovative drug design strategies focused on IDPs [5][28].

One promising strategy involves the modulation of IDP degradation through proteasome activation. This approach aims to regulate the accumulation of IDPs associated with pathological conditions by enhancing their degradation, thus potentially mitigating the adverse effects of their dysregulation [24]. Additionally, the development of small molecules that specifically target IDP interactions has gained traction. These compounds can disrupt aberrant protein-protein interactions, providing a means to counteract the pathological consequences of dysregulated IDPs [22][29].

Moreover, IDPs are increasingly recognized as viable drug targets due to their involvement in various diseases. The ability to exploit the structural features of IDPs for drug targeting has led to the identification of low-molecular-weight inhibitors that can modulate IDP functions, thereby offering new avenues for therapeutic intervention [5][30].

In summary, intrinsically disordered proteins are critical players in cellular processes and disease mechanisms, presenting unique challenges and opportunities for drug development. The exploration of IDPs as therapeutic targets is a burgeoning field, with ongoing research focused on developing innovative strategies to harness their dynamic nature for effective drug discovery and treatment of complex diseases.

5.2 Potential Biomarkers for Disease ​

Intrinsically disordered proteins (IDPs) play significant roles in various biological processes and have profound implications for therapeutic strategies and disease biomarkers. IDPs are characterized by their lack of a stable three-dimensional structure, which enables them to engage in dynamic interactions with multiple partners, making them essential regulators in cellular signaling and other physiological functions.

One of the key roles of IDPs is their involvement in the progression of numerous diseases, including cancer, neurodegenerative disorders, and metabolic diseases. For instance, IDPs often participate in disease-associated protein-protein interaction networks. They can act as hub proteins that facilitate complex interactions; an example is the tumor suppressor protein p53, which is an intrinsically disordered protein and plays a critical role in cellular regulation and cancer biology[21]. Similarly, α-synuclein, linked to Parkinson's disease, is another IDP that functions as a hub in its interaction network, emphasizing the centrality of IDPs in disease mechanisms[21].

The therapeutic implications of IDPs are noteworthy. Due to their flexible nature, they present unique challenges for conventional drug design, which typically relies on well-defined binding pockets. However, recent advances have opened new avenues for targeting IDPs. For instance, strategies such as proteasome activation have been proposed to modulate IDP degradation, potentially addressing the accumulation of these proteins in pathological conditions[24]. Additionally, small molecules that interact with the disordered states of IDPs, such as α-synuclein, have been identified as chemical chaperones, indicating that dual-targeting approaches can be effective in treating diseases like Parkinson's[31].

Furthermore, IDPs are emerging as potential biomarkers for disease due to their involvement in various pathologies. The dysregulation of IDPs can lead to aberrant cellular processes, which are often reflected in the progression of diseases[32]. The identification of low-molecular-weight inhibitors of IDPs has been linked to therapeutic interventions, showcasing their potential as drug targets[30]. The unique structural features of IDPs, such as their high flexibility and random coil-like conformations, enable them to interact with multiple partners, making them valuable candidates for biomarker development[21].

In summary, intrinsically disordered proteins are crucial players in cellular processes and disease mechanisms. Their unique properties not only facilitate complex biological interactions but also position them as promising targets for therapeutic interventions and potential biomarkers for various diseases. Continued research into IDPs will likely yield further insights into their roles in health and disease, ultimately enhancing drug discovery efforts and improving patient outcomes.

6 Future Directions in IDP Research ​

6.1 Emerging Techniques and Approaches ​

Intrinsically disordered proteins (IDPs) play crucial roles in various biological processes due to their unique structural characteristics. Unlike traditional proteins, IDPs lack a stable three-dimensional structure, which allows them to engage in multiple interactions with different biomolecules, thereby facilitating diverse cellular functions. Their conformational malleability enables them to perform specialized roles that cannot be achieved by globular proteins. IDPs are involved in cellular signaling, regulation, and the assembly of signaling complexes, as well as in the formation of membrane-less organelles, thereby adding complexity to regulatory networks and providing mechanisms for tissue-specific signaling [12].

IDPs often act as scaffolds or regulatory hubs, enabling them to trigger biomolecular condensation, which is critical for controlling various biological aspects, including transcriptional and post-transcriptional processes [5]. Their ability to mediate specific biological outcomes through multivalent weak cooperative interactions with multiple partners is a distinguishing feature, allowing them to facilitate complex interactions necessary for cellular functions [13].

The understanding of IDPs has significant implications for future research directions. One promising area involves the exploration of IDPs in the context of disease. Given their extensive involvement in critical diseases such as cancers and neurodegenerative disorders, there is a growing interest in identifying inhibitors that can modulate IDP interactions. This focus is essential as IDPs often engage in high-specificity/low-affinity interactions that play pivotal roles in disease mechanisms [22].

Emerging techniques and approaches in IDP research include the integration of experimental and computational methods to better understand their complex dynamics and interactions. Advanced molecular modeling techniques are being utilized to explore the structural and kinetic details of disordered biomolecular complexes, which are often challenging to unveil experimentally due to their inherent conformational heterogeneity [15]. Furthermore, the use of bioinformatics tools has been instrumental in characterizing disordered regions and elucidating their functional roles in various biological contexts [8].

Additionally, the exploration of IDPs in plant biology has opened new avenues for understanding their roles in developmental processes and responses to environmental stimuli. IDPs in plants are implicated in the perception and propagation of developmental cues, as well as in defense mechanisms against abiotic and biotic stress [11].

In summary, the role of intrinsically disordered proteins is multifaceted, encompassing their participation in cellular signaling, regulatory mechanisms, and the assembly of protein complexes. Future research will likely focus on their implications in disease, the development of inhibitors, and the application of advanced computational techniques to further elucidate their functional dynamics. This ongoing investigation will enhance our understanding of IDPs and their significance in both health and disease contexts.

6.2 Unexplored Roles of IDPs ​

Intrinsically disordered proteins (IDPs) play crucial roles in a variety of biological processes due to their unique structural characteristics. Unlike globular proteins, IDPs lack stable three-dimensional structures, which allows them to interact with multiple partners and perform diverse functions. This intrinsic disorder facilitates their participation in cellular signaling and regulatory mechanisms, enabling them to undertake different interactions with various consequences. For instance, IDPs are involved in the assembly of signaling complexes and the dynamic self-assembly of membrane-less organelles, which are essential for cellular organization and function [12].

The conformational malleability of IDPs allows them to recognize other biomolecules and regulate biological processes effectively. This ability is linked to their role in signaling pathways, where they can mediate specific biological outcomes through multivalent weak cooperative interactions with multiple partners [15]. Additionally, IDPs can undergo post-translational modifications and alternative splicing, which further complicates regulatory networks and provides mechanisms for tissue-specific signaling [12].

Recent studies have highlighted the importance of IDPs in processes such as transcriptional regulation and gene silencing. In plants, for example, IDPs have been shown to control various aspects of nuclear transcription and cytoplasmic post-transcriptional processes, illustrating their critical role in gene expression regulation [5]. Furthermore, IDPs are implicated in the evolution of complex multicellularity, as they can rewire cellular protein interaction networks to facilitate specialized multicellular functions [13].

Future directions in IDP research may involve exploring unexplored roles of these proteins, particularly in relation to their dynamic nature and interactions. Understanding the structural and kinetic details of IDP interactions remains a challenge due to their inherent conformational heterogeneity. Thus, computational approaches, in conjunction with experimental data, are essential for elucidating the functional mechanisms of IDPs [15]. Additionally, there is potential for biotechnological applications of IDPs, such as their use in drug design and development, given their unique properties and roles in various diseases [22].

In summary, the role of intrinsically disordered proteins is multifaceted, encompassing participation in signaling pathways, regulation of gene expression, and the evolution of complex biological systems. Continued research into their unexplored roles and mechanisms will enhance our understanding of cellular processes and may lead to novel therapeutic strategies.

7 Conclusion ​

Intrinsically disordered proteins (IDPs) represent a transformative aspect of molecular biology, challenging the conventional views of protein structure and function. The key findings of this review highlight the critical roles IDPs play in cellular signaling, regulation, and protein-protein interactions, underscoring their significance in maintaining cellular homeostasis and facilitating complex biological processes. The evaluation of current research reveals a growing recognition of IDPs as essential components in health and disease, particularly in neurodegenerative disorders and cancer biology. Despite the challenges posed by their dynamic nature, innovative methodologies are paving the way for deeper insights into IDP functions. Future research directions should focus on exploring the unexplored roles of IDPs, their implications in various diseases, and the development of therapeutic strategies that target these versatile proteins. By harnessing the unique properties of IDPs, researchers can uncover new avenues for drug discovery and biomarker identification, ultimately contributing to advancements in biomedicine and therapeutic interventions.

References ​

  • [1] Vladimir N Uversky. Multitude of binding modes attainable by intrinsically disordered proteins: a portrait gallery of disorder-based complexes.. Chemical Society reviews(IF=39.0). 2011. PMID:21049125. DOI: 10.1039/c0cs00057d.
  • [2] Mihaly Varadi;Wim Vranken;Mainak Guharoy;Peter Tompa. Computational approaches for inferring the functions of intrinsically disordered proteins.. Frontiers in molecular biosciences(IF=4.0). 2015. PMID:26301226. DOI: 10.3389/fmolb.2015.00045.
  • [3] Ivo C Martins;Nuno C Santos. Intrinsically disordered protein domains in flavivirus infection.. Archives of biochemistry and biophysics(IF=3.0). 2020. PMID:32045581. DOI: 10.1016/j.abb.2020.108298.
  • [4] Priya R Banerjee;Alex S Holehouse;Richard Kriwacki;Paul Robustelli;Hao Jiang;Alexander I Sobolevsky;Jennifer M Hurley;Joshua T Mendell. Dissecting the biophysics and biology of intrinsically disordered proteins.. Trends in biochemical sciences(IF=11.0). 2024. PMID:37949765. DOI: 10.1016/j.tibs.2023.10.002.
  • [5] Baoshuan Shang;Changhao Li;Xiuren Zhang. How intrinsically disordered proteins order plant gene silencing.. Trends in genetics : TIG(IF=16.3). 2024. PMID:38296708. DOI: 10.1016/j.tig.2023.12.009.
  • [6] Caolitao Qin;Yun-Long Wang;Jian Zheng;Xiang-Bo Wan;Xin-Juan Fan. Current perspectives in drug targeting intrinsically disordered proteins and biomolecular condensates.. BMC biology(IF=4.5). 2025. PMID:40325419. DOI: 10.1186/s12915-025-02214-x.
  • [7] Frederik Lermyte. Roles, Characteristics, and Analysis of Intrinsically Disordered Proteins: A Minireview.. Life (Basel, Switzerland)(IF=3.4). 2020. PMID:33266184. DOI: 10.3390/life10120320.
  • [8] Timothy H Click;Debabani Ganguly;Jianhan Chen. Intrinsically disordered proteins in a physics-based world.. International journal of molecular sciences(IF=4.9). 2010. PMID:21614208. DOI: 10.3390/ijms11125292.
  • [9] Vladimir N Uversky;Christopher J Oldfield;A Keith Dunker. Intrinsically disordered proteins in human diseases: introducing the D2 concept.. Annual review of biophysics(IF=13.7). 2008. PMID:18573080. DOI: 10.1146/annurev.biophys.37.032807.125924.
  • [10] Prerna Malaney;Vladimir N Uversky;Vrushank Davé. Identification of intrinsically disordered regions in PTEN and delineation of its function via a network approach.. Methods (San Diego, Calif.)(IF=4.3). 2015. PMID:25449897. DOI: .
  • [11] Alejandra A Covarrubias;Paulette S Romero-Pérez;Cesar L Cuevas-Velazquez;David F Rendón-Luna. The functional diversity of structural disorder in plant proteins.. Archives of biochemistry and biophysics(IF=3.0). 2020. PMID:31870661. DOI: 10.1016/j.abb.2019.108229.
  • [12] Peter E Wright;H Jane Dyson. Intrinsically disordered proteins in cellular signalling and regulation.. Nature reviews. Molecular cell biology(IF=90.2). 2015. PMID:25531225. DOI: 10.1038/nrm3920.
  • [13] Prakash Kulkarni;Amita Behal;Atish Mohanty;Ravi Salgia;Aurora M Nedelcu;Vladimir N Uversky. Co-opting disorder into order: Intrinsically disordered proteins and the early evolution of complex multicellularity.. International journal of biological macromolecules(IF=8.5). 2022. PMID:34998872. DOI: 10.1016/j.ijbiomac.2021.12.182.
  • [14] Jianhan Chen. Towards the physical basis of how intrinsic disorder mediates protein function.. Archives of biochemistry and biophysics(IF=3.0). 2012. PMID:22579883. DOI: 10.1016/j.abb.2012.04.024.
  • [15] Ilinka Clerc;Amin Sagar;Alessandro Barducci;Nathalie Sibille;Pau Bernadó;Juan Cortés. The diversity of molecular interactions involving intrinsically disordered proteins: A molecular modeling perspective.. Computational and structural biotechnology journal(IF=4.1). 2021. PMID:34285781. DOI: 10.1016/j.csbj.2021.06.031.
  • [16] Mi-Kyung Yoon;Diana M Mitrea;Li Ou;Richard W Kriwacki. Cell cycle regulation by the intrinsically disordered proteins p21 and p27.. Biochemical Society transactions(IF=4.3). 2012. PMID:22988851. DOI: 10.1042/BST20120092.
  • [17] Z Peng;B Xue;L Kurgan;V N Uversky. Resilience of death: intrinsic disorder in proteins involved in the programmed cell death.. Cell death and differentiation(IF=15.4). 2013. PMID:23764774. DOI: 10.1038/cdd.2013.65.
  • [18] Prakash Kulkarni;Vitor B P Leite;Susmita Roy;Supriyo Bhattacharyya;Atish Mohanty;Srisairam Achuthan;Divyoj Singh;Rajeswari Appadurai;Govindan Rangarajan;Keith Weninger;John Orban;Anand Srivastava;Mohit Kumar Jolly;Jose N Onuchic;Vladimir N Uversky;Ravi Salgia. Intrinsically disordered proteins: Ensembles at the limits of Anfinsen's dogma.. Biophysics reviews(IF=3.4). 2022. PMID:38505224. DOI: 10.1063/5.0080512.
  • [19] Prakash Kulkarni;Srisairam Achuthan;Supriyo Bhattacharya;Mohit Kumar Jolly;Sourabh Kotnala;Vitor B P Leite;Atish Mohanty;John Orban;Susmita Roy;Govindan Rangarajan;Ravi Salgia. Protein conformational dynamics and phenotypic switching.. Biophysical reviews(IF=3.7). 2021. PMID:35059032. DOI: 10.1007/s12551-021-00858-x.
  • [20] Xiaolin Sun;Erik H A Rikkerink;William T Jones;Vladimir N Uversky. Multifarious roles of intrinsic disorder in proteins illustrate its broad impact on plant biology.. The Plant cell(IF=11.6). 2013. PMID:23362206. DOI: 10.1105/tpc.112.106062.
  • [21] Jihua Wang;Zanxia Cao;Liling Zhao;Shuqiang Li. Novel strategies for drug discovery based on Intrinsically Disordered Proteins (IDPs).. International journal of molecular sciences(IF=4.9). 2011. PMID:21686180. DOI: 10.3390/ijms12053205.
  • [22] Daniela Marasco;Pasqualina Liana Scognamiglio. Identification of inhibitors of biological interactions involving intrinsically disordered proteins.. International journal of molecular sciences(IF=4.9). 2015. PMID:25849651. DOI: 10.3390/ijms16047394.
  • [23] Rostislav Skrabana;Jozef Sevcik;Michal Novak. Intrinsically disordered proteins in the neurodegenerative processes: formation of tau protein paired helical filaments and their analysis.. Cellular and molecular neurobiology(IF=4.8). 2006. PMID:16779670. DOI: 10.1007/s10571-006-9083-3.
  • [24] Qian Yu;Zheng Wang;Yutong Tu;Yu Cao;Huajian Zhu;Jiaan Shao;Rangxiao Zhuang;Yubo Zhou;Jiankang Zhang. Proteasome activation: A novel strategy for targeting undruggable intrinsically disordered proteins.. Bioorganic chemistry(IF=4.7). 2024. PMID:38368657. DOI: 10.1016/j.bioorg.2024.107217.
  • [25] Patricia Santofimia-Castaño;Bruno Rizzuti;Yi Xia;Olga Abian;Ling Peng;Adrián Velázquez-Campoy;José L Neira;Juan Iovanna. Targeting intrinsically disordered proteins involved in cancer.. Cellular and molecular life sciences : CMLS(IF=6.2). 2020. PMID:31667555. DOI: 10.1007/s00018-019-03347-3.
  • [26] Bálint Mészáros;Borbála Hajdu-Soltész;András Zeke;Zsuzsanna Dosztányi. Mutations of Intrinsically Disordered Protein Regions Can Drive Cancer but Lack Therapeutic Strategies.. Biomolecules(IF=4.8). 2021. PMID:33806614. DOI: 10.3390/biom11030381.
  • [27] Susmitha Ambadipudi;Markus Zweckstetter. Targeting intrinsically disordered proteins in rational drug discovery.. Expert opinion on drug discovery(IF=4.9). 2016. PMID:26549326. DOI: 10.1517/17460441.2016.1107041.
  • [28] Suman Saurabh;Karthik Nadendla;Shubh Sanket Purohit;Ponnurengam Malliappan Sivakumar;Sibel Cetinel. Fuzzy Drug Targets: Disordered Proteins in the Drug-Discovery Realm.. ACS omega(IF=4.3). 2023. PMID:36969402. DOI: 10.1021/acsomega.2c07708.
  • [29] Vladimir N Uversky. Intrinsically disordered proteins and novel strategies for drug discovery.. Expert opinion on drug discovery(IF=4.9). 2012. PMID:22559227. DOI: 10.1517/17460441.2012.686489.
  • [30] Yusuke Hosoya;Junko Ohkanda. Intrinsically Disordered Proteins as Regulators of Transient Biological Processes and as Untapped Drug Targets.. Molecules (Basel, Switzerland)(IF=4.6). 2021. PMID:33917117. DOI: 10.3390/molecules26082118.
  • [31] Giuseppe Tagliaferro;Maria Giulia Davighi;Francesca Clemente;Filippo Turchi;Marco Schiavina;Camilla Matassini;Andrea Goti;Amelia Morrone;Roberta Pierattelli;Francesca Cardona;Isabella C Felli. Evidence of α-Synuclein/Glucocerebrosidase Dual Targeting by Iminosugar Derivatives.. ACS chemical neuroscience(IF=3.9). 2025. PMID:40079830. DOI: 10.1021/acschemneuro.4c00618.
  • [32] Anne H S Martinelli;Fernanda C Lopes;Elisa B O John;Célia R Carlini;Rodrigo Ligabue-Braun. Modulation of Disordered Proteins with a Focus on Neurodegenerative Diseases and Other Pathologies.. International journal of molecular sciences(IF=4.9). 2019. PMID:30875980. DOI: 10.3390/ijms20061322.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

Intrinsically Disordered Proteins · Cellular Signaling · Disease Mechanisms

© 2025 MaltSci